Imutex Company
Imutex, a startup with a Phase IIa-ready universal flu vaccine.
Industry:
Deep diagnostics
Headquarters:
London, England, United Kingdom
Founded Date:
2016-01-01
Employees Number:
1-10
Funding Status:
Seed
Total Funding:
$20,450,316.00
Estimated Revenue:
$1M to $10M
Last Funding Type:
Seed
Register and Claim Ownership